Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Leading China biotechs Everest, CStone announce CEO departures

Plus updates from BD, Sema4, Nordic Nanovector and more

August 26, 2022 10:47 PM UTC

A pair of closely watched Chinese biotechs announced the departure of their CEOs late this week, with Everest saying farewell to Kerry Blanchard and Frank Jiang leaving CStone.

In his two years at Everest Medicines Ltd. (HKEX:1952), the former Eli Lilly and Co. (NYSE:LLY) executive led the company to a $519 million IPO on the Hong Kong stock exchange, one of the exchange’s largest ever debuts, and its first drug approval. President and CFO Ian Woo became interim CEO of the company, which said it expects to have a new leader in place within a month...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article